VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29 | -80.1% | 6,768 | -69.4% | 0.00% | – |
| Q2 2023 | $146 | -70.6% | 22,100 | -69.8% | 0.00% | -100.0% |
| Q1 2023 | $497 | -8.1% | 73,200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $541 | -99.9% | 73,200 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $723,000 | -48.5% | 73,200 | -43.2% | 0.00% | -33.3% |
| Q2 2022 | $1,404,000 | -94.5% | 128,800 | -94.3% | 0.00% | -93.6% |
| Q1 2022 | $25,620,000 | -27.8% | 2,265,237 | +0.2% | 0.05% | -25.4% |
| Q4 2021 | $35,467,000 | -2.8% | 2,260,482 | +6.2% | 0.06% | -4.5% |
| Q3 2021 | $36,492,000 | -8.3% | 2,129,097 | +15.1% | 0.07% | -2.9% |
| Q2 2021 | $39,794,000 | +100.9% | 1,850,048 | +40.3% | 0.07% | +100.0% |
| Q1 2021 | $19,811,000 | +295.4% | 1,318,982 | +245.8% | 0.03% | +277.8% |
| Q4 2020 | $5,011,000 | – | 381,417 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |